DE3869010D1 - Miocamycin enthaltende pharmazeutische zusammensetzungen fuer die topische anwendung. - Google Patents

Miocamycin enthaltende pharmazeutische zusammensetzungen fuer die topische anwendung.

Info

Publication number
DE3869010D1
DE3869010D1 DE8888830287T DE3869010T DE3869010D1 DE 3869010 D1 DE3869010 D1 DE 3869010D1 DE 8888830287 T DE8888830287 T DE 8888830287T DE 3869010 T DE3869010 T DE 3869010T DE 3869010 D1 DE3869010 D1 DE 3869010D1
Authority
DE
Germany
Prior art keywords
miocamycin
pharmaceutical compositions
topical use
containing pharmaceutical
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888830287T
Other languages
English (en)
Inventor
Mario Ghelardoni
Raffaello Bani
Roberto Massimo Carlesi
Francesco Melani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menarini Industrie Farmaceutiche Riunite SRL
Original Assignee
Menarini Industrie Farmaceutiche Riunite SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Industrie Farmaceutiche Riunite SRL filed Critical Menarini Industrie Farmaceutiche Riunite SRL
Application granted granted Critical
Publication of DE3869010D1 publication Critical patent/DE3869010D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE8888830287T 1987-07-08 1988-07-07 Miocamycin enthaltende pharmazeutische zusammensetzungen fuer die topische anwendung. Expired - Fee Related DE3869010D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT09430/87A IT1222309B (it) 1987-07-08 1987-07-08 Utilizzazione di forme farmaceutiche per uso topico contenenti miocamicina per la terapia delle infezione da germi sensibili alla miocamicina stessa

Publications (1)

Publication Number Publication Date
DE3869010D1 true DE3869010D1 (de) 1992-04-16

Family

ID=11130039

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888830287T Expired - Fee Related DE3869010D1 (de) 1987-07-08 1988-07-07 Miocamycin enthaltende pharmazeutische zusammensetzungen fuer die topische anwendung.

Country Status (7)

Country Link
EP (1) EP0302836B1 (de)
JP (1) JPS6429317A (de)
AT (1) ATE73337T1 (de)
DE (1) DE3869010D1 (de)
ES (1) ES2039289T3 (de)
GR (1) GR3004655T3 (de)
IT (1) IT1222309B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641503A (en) * 1989-04-27 1997-06-24 Mcneil-Ppc, Inc. Additives to tampons
NZ250714A (en) * 1990-10-30 1996-05-28 Mcneil Ppc Inc Liquid composition comprising esters of higher fatty acids for use as a vaginal douche and to prevent toxic shock toxin production
NZ264247A (en) * 1990-10-30 1996-07-26 Mcneil Ppc Inc Absorbent product containing mono- or diesters of a polyhydric alcohol and a c8-18 fatty acid having at least one free hydroxyl group in sufficient amount to inhibit the production of enterotoxins a, b and c by staph. aureus
EP0721324A1 (de) * 1993-10-01 1996-07-17 The Procter & Gamble Company Verwendung von azithromycin zur behandlung von paradontose bei erwachsenen und topische zubereitungen für die verwendung
DE4341139C1 (de) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
CN1096862C (zh) 1994-05-06 2002-12-25 辉瑞大药厂 阿齐霉素的控释剂型
CN101897662B (zh) * 2002-07-23 2013-05-22 诺瓦提斯公司 包含药物、软膏基质和增溶剂/分散剂的眼用软膏剂组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335115A (en) * 1976-11-01 1982-06-15 The Procter & Gamble Company Anti-acne composition
JPS59104326A (ja) * 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
CH643138A5 (de) * 1983-08-29 1984-05-30 Mepha Ag Indomethacin enthaltende, gelartige salbe.

Also Published As

Publication number Publication date
IT1222309B (it) 1990-09-05
ES2039289T3 (es) 1993-09-16
IT8709430A0 (it) 1987-07-08
EP0302836A1 (de) 1989-02-08
GR3004655T3 (de) 1993-04-28
JPS6429317A (en) 1989-01-31
ATE73337T1 (de) 1992-03-15
EP0302836B1 (de) 1992-03-11

Similar Documents

Publication Publication Date Title
ES2196092T3 (es) Composicion antibacteriana liposomica, de baja rigidez.
IT1253711B (it) Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
ATE144704T1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
DE3650741D1 (de) Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
NO922232L (no) Fysiologisk aktive, polypeptid-holdige, farmasoeytiske preparater
DE60123277D1 (de) Makrolidantibiotika
AR004510A1 (es) Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
FI974385A0 (fi) Anvaendning av xylitol foer bekaempning av jaestinfektion och xylitolpreparat foer denna anvaendning
LU88684I2 (fr) Complexe lipidique d'amphotericine b ainsi que leurs dérivés pharmaceutiquement acceptables (abelcet )
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
ES2044843T3 (es) Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos.
ATE246192T1 (de) Ethyliden-derivate tricyclyscher carbapenems
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
DE3869010D1 (de) Miocamycin enthaltende pharmazeutische zusammensetzungen fuer die topische anwendung.
KR950026524A (ko) 피부질환 치료용 의약조성물
NO172043C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
ES2098455T3 (es) Compuestos de ciclohexapeptidil propanolamina.
JPS6466128A (en) Cyclic peptide as absorption accelerator
ES2052922T3 (es) Nucleosidos terapeuticos.
KR920703060A (ko) 제약학적 배합물
ATE24398T1 (de) Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem glycosid antibiotikum und einem hilfsstoff.
ATE83657T1 (de) Pharmazeutische zusammensetzung.
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
MX9303985A (es) Nucleosidos terapeuticos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee